Added
- 7702 Agranulocytosis, acquired:
- Requiring bone marrow transplant;
- or infections recurring, on average, at least once every six weeks per 12-month period | 100
- Requiring intermittent myeloid growth factors (granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) or continuous immunosuppressive therapy such as cyclosporine to maintain absolute neutrophil count (ANC) greater than 500/microliter (µl) but less than 1000/µl;
- or infections recurring, on average, at least once every three months per 12-month period | 60
- Requiring intermittent myeloid growth factors to maintain ANC greater than 1000/µl;
- or infections recurring, on average, at least once per 12-month period but less than once every three months per 12-month period | 30
- Requiring continuous medication (e.g., antibiotics) for control;
and 166 more added passages
Removed
- Link to an amendment published at 83 FR 54254, Oct.
- Link to a correction published at 83 FR 54881, Nov.
- 7700 Anemia, hypochromic-microcytic and megaloblastic, such as iron-deficiency and pernicious anemia:
- Hemoglobin 5gm/100ml or less, with findings such as high output congestive heart failure or dyspnea at rest | 100
- Hemoglobin 7gm/100ml or less, with findings such as dyspnea on mild exertion, cardiomegaly, tachycardia (100 to 120 beats per minute) or syncope (three episodes in the last six months) | 70
- Hemoglobin 8gm/100ml or less, with findings such as weakness, easy fatigability, headaches, lightheadedness, or shortness of breath | 30
and 62 more removed passages